Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2009
12/10/2009US20090305344 Chimeric alphavirus replicon particles
12/10/2009US20090305343 Method For Expressing Polypeptides In Eukaryotic Cells Using Alternative Splicing
12/10/2009US20090305342 Solubilization and Purification of a Target Protein fused to a Mutant Maltose-Binding Protein
12/10/2009US20090305341 HCL-K1 Polypeptide Which Offers Collectin Activity
12/10/2009US20090305340 Altered peptide ligands of gad65
12/10/2009US20090305339 Polypeptides With Laccase Activity
12/10/2009US20090305328 Method of improvement of organisms using profiling the flux sum of metabolites
12/10/2009US20090305320 Method of detecting activation of notch signal transmission system
12/10/2009US20090305316 mutant protein of PQQ-dependent s-GDH (glucose dehydrogenase) with the A. calcoaceticus s-GDH wild-type sequence; for measurement of glucose, especially by a tests strip device or with a biosensor
12/10/2009US20090305309 Methods and Compositions for Detecting Neoplastic Cells
12/10/2009US20090305292 Dna polymerase
12/10/2009US20090305289 Screening method to identify protective substances for the treatment of neurodegenerative and/or ischaemic diseases
12/10/2009US20090305286 Method for the Identification of Suitable Fragmentation Sites in a Reporter Protein
12/10/2009US20090305283 thermostable FEN-1 endonuclease and a polymerase; site-specific nuclease cleavage by a variety of enzymes
12/10/2009US20090305281 Novel inhibitors of retroviral reverse transcriptace
12/10/2009US20090305280 Luciferase biosensors for camp
12/10/2009US20090305278 Sequence determination in confined regions
12/10/2009US20090305275 DNAs AND PROTEINS OR PEPTIDES SPECIFIC TO BACTERIA OF THE SPECIES NEISSERIA MENINGITIDIS, PROCESS FOR OBTAINING THEM AND THEIR BIOLOGICAL USES
12/10/2009US20090305272 Method of characterizing endogenous polynucleotide-polypeptide interactions
12/10/2009US20090305241 DNA demethylases and uses thereof
12/10/2009US20090305240 Method for detection of microorganism and kit for detection of microorganism
12/10/2009US20090304901 Modulating plant protein levels
12/10/2009US20090304889 Plants having an increased content of amino sugars
12/10/2009US20090304858 Phosphoadenylyl Sulfate Reductase Gene and Use Thereof
12/10/2009US20090304817 Glycosylation Variants of Ricin-Like Proteins
12/10/2009US20090304814 Fibrillation resistant proteins
12/10/2009US20090304798 Methods and compositions for therapeutic use of RNA interference
12/10/2009US20090304796 Nanoparticle suitable for delivery of a biomolecule into or out of a membrane enclosed cell or cell organelle
12/10/2009US20090304752 Hypoallergenic variants of the major allergen from betula verrucosa pollen
12/10/2009US20090304745 Chimeric alphavirus replicon particles
12/10/2009US20090304740 Use in HIV vaccines; HIV envelope proteins modified to expose the CD4 binding region
12/10/2009US20090304736 Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera
12/10/2009US20090304728 Tem8 gene, expression forms and diagnostic and therapeutic uses thereof
12/10/2009US20090304727 Hypoallergenic chimeric proteins belonging to the lipid transfer family of parietaria judaica for use in the treatment of allergies
12/10/2009US20090304721 Toxin conjugated eph receptor antibodies
12/10/2009US20090304719 Activatable binding polypeptides and methods of identification and use thereof
12/10/2009US20090304717 Immuno-RNA-Constructs
12/10/2009US20090304713 Binding agents
12/10/2009US20090304710 Novel anti-cd38 antibodies for the treatment of cancer
12/10/2009US20090304708 Preparation for the Prevention and/or Treatment of a Tissue Change of Mesenchymal Origin
12/10/2009US20090304703 Compositions and methods for the diagnosis and treatment of immune disorders
12/10/2009US20090304701 Antibodies binding il-1 related polypeptides
12/10/2009US20090304696 Single Chain FC Polypeptides
12/10/2009US20090304693 Dual Variable Domain Immunoglobulins and Uses Thereof
12/10/2009US20090304690 Glycosylation Engineering of Antibodies for Improving Antibody-Dependent Cellular Cytotoxicity
12/10/2009US20090304683 Soluble Fragments of The Sars-Cov Spike Glycoprotein
12/10/2009US20090304678 Means for Inhibiting the Expression of Protein Kinase 3
12/10/2009US20090304657 Chimeric t cell receptors and related materials and methods of use
12/10/2009US20090304652 Identification and selection of stem cells being committed to differentiate to a specific type for obtaining a homogeneous population of stem cells
12/10/2009US20090304651 Insulin-Like Growth Factor II (IGF-II) Binding Factors
12/10/2009US20090304641 Methods and Compositions for Regulating Gene Expression
12/10/2009US20090304637 Recombinant mycobacterium strain expressing a mycobacterial fap protein under the control of a promoter active under hypoxia and its application for cancer therapy
12/10/2009US20090304595 Animal model and a method for producing an animal model
12/10/2009US20090304588 Biologically excitable cells
12/10/2009US20090304577 Peptides for Treatment and Diagnosis of Autoimmune Disease
12/10/2009CA2764456A1 Oligonucleotide duplexes comprising dna-like and rna-like nucleotides and uses thereof
12/10/2009CA2763791A1 Pluripotency associated epigenetic factor
12/10/2009CA2728556A1 Method for assessing embryotoxicity
12/10/2009CA2727104A1 System for packaging high-capacity adenoviruses
12/10/2009CA2727015A1 Treatment of pain with gap junction modulation compounds
12/10/2009CA2727005A1 Variants of a family 44 xyloglucanase
12/10/2009CA2726990A1 Methods for the production of ips cells using non-viral approach
12/10/2009CA2726885A1 Sirna of human osteopontin
12/10/2009CA2726804A1 Xbp1, cd138, and cs1 peptides
12/10/2009CA2726803A1 Variant alpha-amylases from bacillus subtilis and methods of use, thereof
12/10/2009CA2726743A1 Novel genes involved in biosynthesis
12/10/2009CA2726598A1 Controllable assembly and disassembly of nanoparticle systems via protein and dna agents
12/10/2009CA2726489A1 Fatty acid dehydratases and uses thereof
12/10/2009CA2726345A1 Interleukin-1 alpha abs and methods of use
12/10/2009CA2726293A1 Non-hemolytic clya for excretion of proteins
12/10/2009CA2726285A1 Anxiolytic composition containing alphas1-casein-derived peptides
12/10/2009CA2726274A1 Variant alpha-amylases from bacillus subtilis and methods of use, thereof
12/10/2009CA2726193A1 Methods of treating inflammatory intestinal disease and managing symptoms thereof
12/10/2009CA2726128A1 Cell line, system and method for optical control of secondary messengers
12/10/2009CA2725666A1 Dual variable domain immunoglobulins and uses thereof
12/10/2009CA2725631A1 Method for isolating nucleic acids
12/10/2009CA2724425A1 Process of producing male sterile monocotyledonous plants
12/10/2009CA2723874A1 Deletion mutants for the production of isobutanol
12/09/2009EP2130927A1 Method for amplification of dna fragment
12/09/2009EP2130926A2 Phage microarray profiling of the humoral response to disease
12/09/2009EP2130922A1 Improved halohydrin epoxidase
12/09/2009EP2130921A2 Vaccine for prevention and treatment of HIV-infection
12/09/2009EP2130920A2 Beta-like glycoprotein hormone polypeptide and heterodimer
12/09/2009EP2130919A1 IL-21 antagonists
12/09/2009EP2130918A1 Method for creating a variant library of DNA sequences
12/09/2009EP2130917A1 Probe for detecting polymorphism in gene involved in immunity, and use thereof
12/09/2009EP2130916A1 E. coli capable of expressing cytochrome p-450, and bioconversion method using the same
12/09/2009EP2130915A1 Cell capable of expressing lacritin at high level
12/09/2009EP2130914A1 Novel glycosyltransferase and polynucleotide encoding the same
12/09/2009EP2130913A1 Chip for sampling cell component, system for analyzing cell component and method of analyzing cell component using the same
12/09/2009EP2130840A1 Antibody producing microorganism, elements required to obtain same, resulting antibodies, therapeutic compositions and use of thereof
12/09/2009EP2130839A2 AXMI-027, AXMI-036 and AXMI-038, a family of delta-endotoxin genes and methods for their use
12/09/2009EP2130552A1 Pharmaceutical composition comprising anti-grp78 antibody as active ingredient
12/09/2009EP2130551A1 Improved purification of collagenases from clostridium histolyticum liquid culture
12/09/2009EP2129799A1 Methods of stratifying adolescent idiopathic scoliosis, isolated nucleic acid molecules for use in same and kits using same
12/09/2009EP2129790A2 Selection of high-producing cell lines
12/09/2009EP2129786A1 Method for the production of l-amino acids using strains of the enterobacteriaceae<i></i>family
12/09/2009EP2129783A1 Transgenic plant with increased stress tolerance and yield
12/09/2009EP2129782A1 Modified microorganism
12/09/2009EP2129780A2 Compositions, systems, and methods for preservation and/or stabilization of a cell and/or macromolecule
1 ... 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 ... 4023